Status:
TERMINATED
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer
Lead Sponsor:
Stiftung Swiss Tumor Institute
Collaborating Sponsors:
Klinik Hirslanden, Zurich
Manja Gideon Foundation
Conditions:
Patient Reported Outcome Measures
Ovarian Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer...
Detailed Description
The observational study will examine different follow-up modalities for ovarian cancer patients with the ultimate goal of improving follow-up strategies for an improved well-being and better clinical ...
Eligibility Criteria
Inclusion
- Women aged ≥ 18 years
- Between diagnosis and the first follow-up visit after the end of their antineoplastic treatment (systemic therapy or surgical treatment) for ovarian cancer.
- German, English, French, or Italian speaking
- Personal smartphone (iOS or Android system); one of the latest three main versions
Exclusion
- • Patients whose compliance must be questioned, e.g. due to a psychiatric disorder, private life situation or insufficient knowledge on smartphone use and do not have a suitable caregiver to assist them with symptom reporting.
Key Trial Info
Start Date :
December 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05352217
Start Date
December 13 2021
End Date
November 13 2023
Last Update
April 22 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Spital Limmattal Frauenklinik
Schlieren, Canton of Zurich, Switzerland, 8952
2
Gynäkologische Onkologie Spital Zollikerberg
Zollikerberg, Canton of Zurich, Switzerland, 8125
3
Praxis für Gynäkologie und Geburtshilfe
Zurich, Switzerland, 8002
4
Interdisziplinäre Medizin Zürich (IMZ)
Zurich, Switzerland, 8008